IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v18y2021i11p6141-d570004.html
   My bibliography  Save this article

Lack of Informations about COVID-19 Vaccine: From Implications to Intervention for Supporting Public Health Communications in COVID-19 Pandemic

Author

Listed:
  • Silva Guljaš

    (Department of Radiology, University Hospital Center Osijek, 31 000 Osijek, Croatia
    Faculty of Medicine, Josip Juraj Strossmayer University of Osijek, 31 000 Osijek, Croatia
    Faculty of Dental Medicine and Health, Josip Juraj Strossmayer University of Osijek, 31 000 Osijek, Croatia)

  • Zvonimir Bosnić

    (Department of Internal Medicine, Family Medicine and the History of Medicine, Faculty of Medicine, Josip Juraj Strossmayer University of Osijek, 31 000 Osijek, Croatia)

  • Tamer Salha

    (Faculty of Medicine, Josip Juraj Strossmayer University of Osijek, 31 000 Osijek, Croatia
    Faculty of Dental Medicine and Health, Josip Juraj Strossmayer University of Osijek, 31 000 Osijek, Croatia
    Department of Teleradiology and Arteficial Intelligence, Health Center Osijek-Baranja County, 31 000 Osijek, Croatia)

  • Monika Berecki

    (Faculty of Medicine, Josip Juraj Strossmayer University of Osijek, 31 000 Osijek, Croatia)

  • Zdravka Krivdić Dupan

    (Department of Radiology, University Hospital Center Osijek, 31 000 Osijek, Croatia
    Faculty of Medicine, Josip Juraj Strossmayer University of Osijek, 31 000 Osijek, Croatia)

  • Stjepan Rudan

    (Faculty of Dental Medicine and Health, Josip Juraj Strossmayer University of Osijek, 31 000 Osijek, Croatia)

  • Ljiljana Majnarić Trtica

    (Department of Internal Medicine, Family Medicine and the History of Medicine, Faculty of Medicine, Josip Juraj Strossmayer University of Osijek, 31 000 Osijek, Croatia
    Department of Public Health, Faculty of Dental Medicine and Health, Josip Juraj Strossmayer University of Osijek, 31 000 Osijek, Croatia)

Abstract

Lack of knowledge and mistrust towards vaccines represent a challenge in achieving the vaccination coverage required for population immunity. The aim of this study is to examine the opinion that specific demographic groups have about COVID-19 vaccination, in order to detect potential fears and reasons for negative attitudes towards vaccination, and to gain knowledge on how to prepare strategies to eliminate possible misinformation that could affect vaccine hesitancy. The data collection approach was based on online questionnaire surveys, divided into three groups of questions that followed the main postulates of the health belief theory—a theory that helps understanding a behaviour of the public in some concrete surrounding in receiving preventive measures. Ordinary least squares regression analyses were used to examine the influence of individual factors on refusing the vaccine, and to provide information on the perception of participants on the danger of COVID-19 infection, and on potential barriers that could retard the vaccine utility. There was an equal proportion of participants (total number 276) who planned on receiving the COVID-19 vaccine (37%), and of those who did not (36.3%). The rest (26.7%) of participants were still indecisive. Our results indicated that attitudes on whether to receive the vaccine, on how serious consequences might be if getting the infection, as well as a suspicious towards the vaccine efficacy and the fear of the vaccine potential side effects, may depend on participants’ age (<40 vs. >40 years) and on whether they are healthcare workers or not. The barriers that make participants‘ unsure about of receiving the vaccine, such as a distrust in the vaccine efficacy and safety, may vary in different socio-demographic groups and depending on which is the point of time in the course of the pandemic development, as well as on the vaccine availability and experience in using certain vaccine formulas. There is a pressing need for health services to continuously provide information to the general population, and to address the root causes of mistrust through improved communication, using a wide range of policies, interventions and technologies.

Suggested Citation

  • Silva Guljaš & Zvonimir Bosnić & Tamer Salha & Monika Berecki & Zdravka Krivdić Dupan & Stjepan Rudan & Ljiljana Majnarić Trtica, 2021. "Lack of Informations about COVID-19 Vaccine: From Implications to Intervention for Supporting Public Health Communications in COVID-19 Pandemic," IJERPH, MDPI, vol. 18(11), pages 1-15, June.
    • Handle: RePEc:gam:jijerp:v:18:y:2021:i:11:p:6141-:d:570004
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/18/11/6141/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/18/11/6141/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Marshall K. Cheney & Robert John, 2013. "Underutilization of Influenza Vaccine," SAGE Open, , vol. 3(2), pages 21582440134, April.
    2. Zijun Wang & Fabian Schmidt & Yiska Weisblum & Frauke Muecksch & Christopher O. Barnes & Shlomo Finkin & Dennis Schaefer-Babajew & Melissa Cipolla & Christian Gaebler & Jenna A. Lieberman & Thiago Y. , 2021. "mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants," Nature, Nature, vol. 592(7855), pages 616-622, April.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Yudong Miao & Yi Li & Wanliang Zhang & Jian Wu & Jianqin Gu & Meiyun Wang & Wei Wei & Beizhu Ye & Chengyuan Miao & Clifford Silver Tarimo & Wenyong Dong, 2022. "The Psychological Experience of COVID-19 Vaccination and Its Impact on the Willingness to Receive Booster Vaccines among the Chinese Population: Evidence from a National Cross-Sectional Study," IJERPH, MDPI, vol. 19(9), pages 1-11, April.
    2. Afnan Alqurashi & Enas A. Sindy & Heba Dosh & Sumaya Z. Khayat & Lujain M. Alqarna & Wafa M. Sodagar & Mohammed Samannodi & Hassan Alwafi & Emad Salawati & Mohammed A. Almatrafi & Rakan Ekram & Rehab , 2022. "Perception and Acceptance of Using Different Generic Types of COVID-19 Vaccine, the “Mix-and-Match” Strategy, in Saudi Arabia: Cross-Sectional Web-Based Survey," IJERPH, MDPI, vol. 19(21), pages 1-10, October.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Kuckertz, Andreas & Scheu, Maximilian, 2024. "From chalkboard to boardroom: Unveiling the role of entrepreneurship in bolstering academic achievement among professors," Journal of Business Research, Elsevier, vol. 175(C).
    2. Kevin J. Kramer & Erin M. Wilfong & Kelsey Voss & Sierra M. Barone & Andrea R. Shiakolas & Nagarajan Raju & Caroline E. Roe & Naveenchandra Suryadevara & Lauren M. Walker & Steven C. Wall & Ariana Pau, 2022. "Single-cell profiling of the antigen-specific response to BNT162b2 SARS-CoV-2 RNA vaccine," Nature Communications, Nature, vol. 13(1), pages 1-20, December.
    3. X. Tong & R. P. McNamara & M. J. Avendaño & E. F. Serrano & T. García-Salum & C. Pardo-Roa & H. L. Bertera & T. M. Chicz & J. Levican & E. Poblete & E. Salinas & A. Muñoz & A. Riquelme & G. Alter & R., 2023. "Waning and boosting of antibody Fc-effector functions upon SARS-CoV-2 vaccination," Nature Communications, Nature, vol. 14(1), pages 1-15, December.
    4. Sissy Therese Sonnleitner & Martina Prelog & Stefanie Sonnleitner & Eva Hinterbichler & Hannah Halbfurter & Dominik B. C. Kopecky & Giovanni Almanzar & Stephan Koblmüller & Christian Sturmbauer & Leon, 2022. "Cumulative SARS-CoV-2 mutations and corresponding changes in immunity in an immunocompromised patient indicate viral evolution within the host," Nature Communications, Nature, vol. 13(1), pages 1-12, December.
    5. João Faro-Viana & Marie-Louise Bergman & Lígia A. Gonçalves & Nádia Duarte & Teresa P. Coutinho & Patrícia C. Borges & Christian Diwo & Rute Castro & Paula Matoso & Vanessa Malheiro & Ana Brennand & L, 2022. "Population homogeneity for the antibody response to COVID-19 BNT162b2/Comirnaty vaccine is only reached after the second dose across all adult age ranges," Nature Communications, Nature, vol. 13(1), pages 1-8, December.
    6. I‐Hui Chen & Shih‐Min Hsu & Jiunn‐Shyan Julian Wu & Yu‐Tsang Wang & Yen‐Kuang Lin & Min‐Huey Chung & Pin‐Hsuan Huang & Nae‐Fang Miao, 2019. "Determinants of nurses’ willingness to receive vaccines: Application of the health belief model," Journal of Clinical Nursing, John Wiley & Sons, vol. 28(19-20), pages 3430-3440, October.
    7. Sebastian Weigang & Jonas Fuchs & Gert Zimmer & Daniel Schnepf & Lisa Kern & Julius Beer & Hendrik Luxenburger & Jakob Ankerhold & Valeria Falcone & Janine Kemming & Maike Hofmann & Robert Thimme & Ch, 2021. "Within-host evolution of SARS-CoV-2 in an immunosuppressed COVID-19 patient as a source of immune escape variants," Nature Communications, Nature, vol. 12(1), pages 1-12, December.
    8. Davida S. Smyth & Monica Trujillo & Devon A. Gregory & Kristen Cheung & Anna Gao & Maddie Graham & Yue Guan & Caitlyn Guldenpfennig & Irene Hoxie & Sherin Kannoly & Nanami Kubota & Terri D. Lyddon & M, 2022. "Tracking cryptic SARS-CoV-2 lineages detected in NYC wastewater," Nature Communications, Nature, vol. 13(1), pages 1-9, December.
    9. Yubin Liu & Ziyi Wang & Xinyu Zhuang & Shengnan Zhang & Zhicheng Chen & Yan Zou & Jie Sheng & Tianpeng Li & Wanbo Tai & Jinfang Yu & Yanqun Wang & Zhaoyong Zhang & Yunfeng Chen & Liangqin Tong & Xi Yu, 2023. "Inactivated vaccine-elicited potent antibodies can broadly neutralize SARS-CoV-2 circulating variants," Nature Communications, Nature, vol. 14(1), pages 1-17, December.
    10. Shakhany, Mohammad Qaleh & Salimifard, Khodakaram, 2021. "Predicting the dynamical behavior of COVID-19 epidemic and the effect of control strategies," Chaos, Solitons & Fractals, Elsevier, vol. 146(C).
    11. Ma’ayan Israeli & Yaara Finkel & Yfat Yahalom-Ronen & Nir Paran & Theodor Chitlaru & Ofir Israeli & Inbar Cohen-Gihon & Moshe Aftalion & Reut Falach & Shahar Rotem & Uri Elia & Ital Nemet & Limor Klik, 2022. "Genome-wide CRISPR screens identify GATA6 as a proviral host factor for SARS-CoV-2 via modulation of ACE2," Nature Communications, Nature, vol. 13(1), pages 1-16, December.
    12. Andrew P. Hederman & Harini Natarajan & Leo Heyndrickx & Kevin K. Ariën & Joshua A. Wiener & Peter F. Wright & Evan M. Bloch & Aaron A. R. Tobian & Andrew D. Redd & Joel N. Blankson & Amihai Rottenstr, 2023. "SARS-CoV-2 vaccination elicits broad and potent antibody effector functions to variants of concern in vulnerable populations," Nature Communications, Nature, vol. 14(1), pages 1-11, December.
    13. Mingxi Li & Yifei Ren & Zhen Qin Aw & Bo Chen & Ziqing Yang & Yuqing Lei & Lin Cheng & Qingtai Liang & Junxian Hong & Yiling Yang & Jing Chen & Yi Hao Wong & Jing Wei & Sisi Shan & Senyan Zhang & Jiwa, 2022. "Broadly neutralizing and protective nanobodies against SARS-CoV-2 Omicron subvariants BA.1, BA.2, and BA.4/5 and diverse sarbecoviruses," Nature Communications, Nature, vol. 13(1), pages 1-17, December.
    14. Chengzi I. Kaku & Tyler N. Starr & Panpan Zhou & Haley L. Dugan & Paul Khalifé & Ge Song & Elizabeth R. Champney & Daniel W. Mielcarz & James C. Geoghegan & Dennis R. Burton & Raiees Andrabi & Jesse D, 2023. "Evolution of antibody immunity following Omicron BA.1 breakthrough infection," Nature Communications, Nature, vol. 14(1), pages 1-13, December.
    15. Leander Witte & Viren A. Baharani & Fabian Schmidt & Zijun Wang & Alice Cho & Raphael Raspe & Camila Guzman-Cardozo & Frauke Muecksch & Marie Canis & Debby J. Park & Christian Gaebler & Marina Caskey , 2023. "Epistasis lowers the genetic barrier to SARS-CoV-2 neutralizing antibody escape," Nature Communications, Nature, vol. 14(1), pages 1-11, December.
    16. Robert M. Cox & Carolin M. Lieber & Josef D. Wolf & Amirhossein Karimi & Nicole A. P. Lieberman & Zachary M. Sticher & Pavitra Roychoudhury & Meghan K. Andrews & Rebecca E. Krueger & Michael G. Natchu, 2023. "Comparing molnupiravir and nirmatrelvir/ritonavir efficacy and the effects on SARS-CoV-2 transmission in animal models," Nature Communications, Nature, vol. 14(1), pages 1-14, December.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:18:y:2021:i:11:p:6141-:d:570004. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.